A profile of health care company GRAIL Inc., includes mention of OHSU’s participation in the PATHFINDER study, the company’s large-scale interventional study for cancer early detection.
Fitbit consulted with OHSU emergency medicine clinicians caring for COVID-19 patients to help inform their design of an emergency ventilator to help save lives during the pandemic.
Research by Luke Masha, M.D., and colleagues finds patients who undergo transcatheter aortic valve replacement are more likely to die a month afterward if they also have cardiogenic shock.
The FDA expands approval of ixekizumab for nonradiographic axial spondyloarthritis; Atul Deodhar, M.D., says: “Today’s FDA approval provides patients with a much-needed treatment option targeting IL-17A to improve the signs and symptoms of nr-axSpA."
Eneida Nemecek, M.D., contributes to the publication of guidelines for combating the spread of COVID-19 while providing protection to transplant patients.